LAP2 is widely overexpressed in diverse digestive tract cancers and regulates motility of cancer cells

Cited 20 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorH J Kim-
dc.contributor.authorS H Hwang-
dc.contributor.authorM E Han-
dc.contributor.authorS Baek-
dc.contributor.authorH E Sim-
dc.contributor.authorS Yoon-
dc.contributor.authorS Y Baek-
dc.contributor.authorB S Kim-
dc.contributor.authorJ H Kim-
dc.contributor.authorSeon-Young Kim-
dc.contributor.authorS O Oh-
dc.date.accessioned2017-04-19T09:31:41Z-
dc.date.available2017-04-19T09:31:41Z-
dc.date.issued2012-
dc.identifier.issn1932-6203-
dc.identifier.uri10.1371/journal.pone.0039482ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/10779-
dc.description.abstractBackground: Lamina-associated polypeptides 2 (LAP2) is a nuclear protein that connects the nuclear lamina with chromatin. Although its critical roles in genetic disorders and hematopoietic malignancies have been described, its expression and roles in digestive tract cancers have been poorly characterized. Methods: To examine the expression of LAP2 in patient tissues, we performed immunohistochemistry and real-time PCR. To examine motility of cancer cells, we employed Boyden chamber, wound healing and Matrigel invasion assays. To reveal its roles in metastasis in vivo, we used a liver metastasis xenograft model. To investigate the underlying mechanism, a cDNA microarray was conducted. Results: Immunohistochemistry in patient tissues showed widespread expression of LAP2 in diverse digestive tract cancers including stomach, pancreas, liver, and bile duct cancers. Real-time PCR confirmed that LAP2β is over-expressed in gastric cancer tissues. Knockdown of LAP2β did not affect proliferation of most digestive tract cancer cells except pancreatic cancer cells. However, knockdown of LAP2β decreased motility of all tested cancer cells. Moreover, overexpression of LAP2β increased motility of gastric and pancreatic cancer cells. In the liver metastasis xenograft model, LAP2β increased metastatic efficacy of gastric cancer cells and mortality in tested mice. cDNA microarrays showed the possibility that myristoylated alanine-rich C kinase substrate (MARCKS) and interleukin6 (IL6) may mediate LAP2β-regulated motility of cancer cells. Conclusions: From the above results, we conclude that LAP2 is widely overexpressed in diverse digestive tract cancers and LAP2β regulates motility of cancer cells and suggest that LAP2β may have utility for diagnostics and therapeutics in digestive tract cancers.-
dc.publisherPublic Library of Science-
dc.titleLAP2 is widely overexpressed in diverse digestive tract cancers and regulates motility of cancer cells-
dc.title.alternativeLAP2 is widely overexpressed in diverse digestive tract cancers and regulates motility of cancer cells-
dc.typeArticle-
dc.citation.titlePLoS One-
dc.citation.number6-
dc.citation.endPagee39482-
dc.citation.startPagee39482-
dc.citation.volume7-
dc.contributor.affiliatedAuthorSeon-Young Kim-
dc.contributor.alternativeName김현정-
dc.contributor.alternativeName황선희-
dc.contributor.alternativeName한명은-
dc.contributor.alternativeName백성민-
dc.contributor.alternativeName심혜은-
dc.contributor.alternativeName윤식-
dc.contributor.alternativeName백선용-
dc.contributor.alternativeName김봉선-
dc.contributor.alternativeName김정환-
dc.contributor.alternativeName김선영-
dc.contributor.alternativeName오세옥-
dc.identifier.bibliographicCitationPLoS One, vol. 7, no. 6, pp. e39482-e39482-
dc.identifier.doi10.1371/journal.pone.0039482-
dc.description.journalClassY-
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:

Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.